Advertisement

Topics

The Rumbaugh-Goodwin Institute for Cancer Research, Inc Company Profile

06:22 EDT 23rd June 2018 | BioPortfolio

The Rumbaugh-Goodwin Institute for Cancer Research, Inc. (RGI) is a not-for-profit research organization founded by Dr. James Reyniers in 1959. Historically, the genesis of RGI was through the LOBUND Institute of the University of Notre Dame, where Dr. Reyniers developed barrier-containment technology. This advance enabled the breeding of small germ-free animals with eventual application of the plastic bubble for immunodeficient patients.
Dr. Reyniers left Notre Dame in 1959 to establish the Germfree Life Research laboratories in Tampa, Florida. For the next ten years they concentrated on understanding the relationship of viruses to cancer. Rapid development of knowledge in the field of tumor immunology resulted in the laboratories refocusing their efforts on the role of immune factors in spontaneous leukemias, mammary tumors, and autoimmune diseases such as multiple sclerosis. The facility subsequently relocated to Fort Lauderdale, Florida, in 1969, where it was renamed the Leo Goodwin Institute for Cancer Research. There, in response to the National Cancer Act of 1971, the Institute established barrier-containment rooms which, under contract with National Cancer Institute, provided large numbers of specific pathogen-free rodents to research laboratories

Location

1850 NW 69th Ave Suite 5
Plantation
Florida
33313
United States of America

Contact

Phone: (954) 587-9020
Email: info@rgicr.org


News Articles [4857 Associated News Articles listed on BioPortfolio]

The Salk Institute and Indivumed collaborate for cutting-edge cancer research

The Salk Institute, which hosts a National Cancer Institute-designated cancer center and Indivumed GmbH, a world leading cancer research company today announce a multi-year strategic alliance to secur...

How might baking soda boost cancer therapy?

(Ludwig Institute for Cancer Research) A Ludwig Cancer Research study led by Chi Van Dang, scientific director of the Ludwig Institute for Cancer Research, has uncovered an entirely novel mechanism by...

Liquid biopsies could be used as new predictive marker for metastatic TNBC

A clinically relevant "liquid biopsy" test can be used to profile cancer genomes from blood and predict survival outcomes for patients with metastatic triple negative breast cancer, according to new r...

Huntsman Cancer Institute opens Center for HOPE

(Huntsman Cancer Institute) Huntsman Cancer Institute (HCI) at the University of Utah (U of U) today announced the opening of the Cancer Population Sciences and Huntsman Center for Health Outcomes and...

#jobs #lifescience Dana-Farber Cancer Institute: Senior Radiochemistry Research Technician

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Dana-Farber Cancer Institute: Senior Radiochemistry Research Technician . Dep...

Van Andel Research Institute scientists help redefine how cancer is categorized

(Van Andel Research Institute) Van Andel Research Institute (VARI) announced today that the work of its scientists is featured in 27 papers focused on the output of The Cancer Genome Atlas (TCGA). The...

Huntsman Cancer Institute selected as a NCI Center for patient-derived model development

(University of Utah) Huntsman Cancer Institute at the University of Utah has been awarded a $2.4 million, two-year grant from the National Cancer Institute to help continue its research in breast canc...

#jobs #lifescience Dana-Farber Cancer Institute: Research Fellow – Breast Immunology Laboratory

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Dana-Farber Cancer Institute: Research Fellow – Breast Immunology Labor...

PubMed Articles [7796 Associated PubMed Articles listed on BioPortfolio]

US National Cancer Institute-China Collaborative Studies on Chinese Medicine and Cancer.

Since 2007, the US National Cancer Institute (NCI) Office of Cancer Complementary and Alternative Medicine (OCCAM), together with the Cancer Institute of the China Academy of Chinese Medical Sciences ...

Updates to the National Cancer Institute's PDQ Information from Recently Published Oncology Research.

State of the Science: Cancer Complementary and Alternative Medicine Therapeutics Research-NCI Strategic Workshop Highlights of Discussion Report.

In May 2016, the Office of Cancer Complementary and Alternative Medicine, Division of Cancer Diagnosis and Treatment, of the National Cancer Institute convened a special workshop focused on the State ...

The National Cancer Institute's Conference on Acupuncture for Symptom Management in Oncology: State of the Science, Evidence, and Research Gaps.

The Division of Cancer Treatment and Diagnosis, Office of Cancer Complementary and Alternative Medicine, at the National Cancer Institute (NCI) held a symposium on "Acupuncture for Cancer Symptom Mana...

Including the Patient Voice in Patient-Centered Outcomes Research in Integrative Oncology.

The objective of this paper is to describe our experience as patient advisors as we work on a Patient-Centered Outcomes Research Institute-funded project, CHoosing Options for Insomnia in Cancer Effec...

Clinical Trials [10431 Associated Clinical Trials listed on BioPortfolio]

Multidrug Resistance Proteins in Patients Enrolled in Clinical Trials Outside of the National Cancer Institute Center for Cancer Research

RATIONALE: Studying samples of tumor tissue or blood from patients with cancer in the laboratory may help doctors learn more about cancer and the development of multidrug resistance in pat...

Cancer Care in the National Cancer Institute Center for Cancer Research

This study provides cancer care through the National Cancer Institute's Medical Oncology Branch (MOB) to patients who are not enrolled in an active treatment research protocol. Patients re...

Addressing Prostate Cancer Information Disparities With eHealth Technology

his is a multicenter study that involves research on screening for prostate cancer. This study pilot tests a culturally appropriate decision aid (DA) for African American (AA) men that wil...

Understanding Male Breast Cancer: Salah Azaïz Cancer Institute Experience

The goal of this study is to evaluate the Salah Azaïz Cancer Institute male breast cancer patients population over a period of 14 years. Goal of the retrospective part: to gather clinico...

Evaluation and Treatment of People With Eye Diseases

This study will evaluate and provide standard treatments for people with various eye conditions. It will provide a resource for enrollment into new research protocols throughout the Eye In...

Companies [3743 Associated Companies listed on BioPortfolio]

Goodwin Institute for Cancer Research

The Rumbaugh-Goodwin Institute for Cancer Research, Inc. (RGI) is a nonprofit cancer research facility dedicated to investigating and studying numerous types of cancer. Our goal is to find a cure or c...

The Rumbaugh-Goodwin Institute for Cancer Research, Inc

The Rumbaugh-Goodwin Institute for Cancer Research, Inc. (RGI) is a not-for-profit research organization founded by Dr. James Reyniers in 1959. Historically, the genesis of RGI was through the LOBUND ...

Goodwin Biotechnology, Inc

Goodwin Biotechnology, Inc. ("GBI"), based in Plantation, Florida, is the earliest established and one of the most experienced contract manufacturing organizations (CMOs) serving the biopharmaceutical...

The Wistar Institute and Christiana Care Health System

The Wistar Institute is an international leader in biomedical research with special expertise in cancer research and vaccine development. Founded in 1892 as the first independent ...

Goodwin Biotechnology Inc.

More Information about "The Rumbaugh-Goodwin Institute for Cancer Research, Inc" on BioPortfolio

We have published hundreds of The Rumbaugh-Goodwin Institute for Cancer Research, Inc news stories on BioPortfolio along with dozens of The Rumbaugh-Goodwin Institute for Cancer Research, Inc Clinical Trials and PubMed Articles about The Rumbaugh-Goodwin Institute for Cancer Research, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Rumbaugh-Goodwin Institute for Cancer Research, Inc Companies in our database. You can also find out about relevant The Rumbaugh-Goodwin Institute for Cancer Research, Inc Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Immunology
Allergies Automimmune Disease Human Papillomavirus (HPV) Immunology Vaccine Immunology is the study of immunity and the defence mechanisms of the body. A greater understanding of immunology is needed to develop vaccines, understand ...


Corporate Database Quicklinks



Searches Linking to this Company Record